BioCorRx (BICX) Short Interest Ratio & Short Volume $0.29 0.00 (0.00%) As of 04/24/2025 Add Compare Share Share Short Interest Stock AnalysisChartEarningsSEC FilingsShort InterestBuy This Stock BioCorRx Short Interest DataBioCorRx (BICX) has a short interest of 8,800 shares, representing 0.07% of the float (the number of shares available for trading by the public). This marks a 23.94% increase in short interest from the previous month. The short interest ratio (days to cover) is 1.2, indicating that it would take 1.2 days of the average trading volume of 12,309 shares to cover all short positions.Current Short Interest8,800 sharesPrevious Short Interest7,100 sharesChange Vs. Previous Month+23.94%Dollar Volume Sold Short$4,382.40Short Interest Ratio1.2 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares16,898,000 sharesShort Percent of Float0.07%Today's Trading Volume71 sharesAverage Trading Volume12,309 sharesToday's Volume Vs. Average1% Short Selling BioCorRx? Sign up to receive the latest short interest report for BioCorRx and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBICX Short Interest Over TimeBICX Days to Cover Over TimeBICX Percentage of Float Shorted Over Time BioCorRx Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20258,800 shares $4,382.40 +23.9%0.1%1.2 $0.50 3/15/20257,100 shares $2,151.30 +222.7%0.1%0.7 $0.30 2/28/20252,200 shares $717.20 -4.4%0.0%22 $0.33 2/15/20252,300 shares $951.05 +4.6%0.0%1.4 $0.41 1/31/20252,200 shares $789.36 No ChangeN/A0 $0.36 11/30/20242,300 shares $690.00 No ChangeN/A11.5 $0.30 9/15/2024400 shares $200.00 -33.3%N/A0.4 $0.50 8/31/2024600 shares $180.00 No ChangeN/A1.2 $0.30 8/15/2024600 shares $252.76 No ChangeN/A0.1 $0.42 4/15/2024800 shares $1,200.00 +100.0%N/A0.3 $1.50 Get the Latest News and Ratings for BICX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioCorRx and its competitors with MarketBeat's FREE daily newsletter. 3/31/2024400 shares $358.00 No ChangeN/A0.2 $0.90 3/15/2024400 shares $368.00 -33.3%N/A0.3 $0.92 2/29/2024600 shares $600.00 No ChangeN/A0.2 $1.00 2/15/2024600 shares $498.00 No ChangeN/A0.9 $0.83 1/15/2024600 shares $420.00 No ChangeN/A0.2 $0.70 12/31/2023600 shares $468.00 -25.0%N/A0.1 $0.78 12/15/2023800 shares $736.00 No ChangeN/A0.2 $0.92 9/30/2023100 shares $175.00 No ChangeN/A1 $1.75 9/15/2023100 shares $175.00 No ChangeN/A1 $1.75 8/31/2023100 shares $168.00 No ChangeN/A0.1 $1.68 7/15/2023100 shares $186.00 No ChangeN/A0 $1.86 2/28/20232,700 shares $5,510.70 No ChangeN/A1.2 $2.04 2/15/20232,700 shares $4,185.00 No ChangeN/A0.7 $1.55 1/31/20232,700 shares $3,888.00 No ChangeN/A1.8 $1.44 1/15/20232,700 shares $2,970.00 No ChangeN/A1.1 $1.10 12/30/20222,700 shares $2,632.50 -3.6%N/A0.6 $0.98 12/15/20222,800 shares $2,240.00 -3.5%N/A0.1 $0.80 11/30/20222,900 shares $5,365.00 No ChangeN/A5.8 $1.85 11/15/20222,900 shares $5,336.00 No ChangeN/A3.6 $1.84 10/31/20222,900 shares $5,220.00 No ChangeN/A1.6 $1.80 10/15/20222,900 shares $5,858.00 No ChangeN/A1.5 $2.02 9/30/20222,900 shares $5,945.00 No ChangeN/A1.3 $2.05 9/15/20222,900 shares $6,264.00 No ChangeN/A2.6 $2.16 8/31/20222,900 shares $6,206.00 No ChangeN/A1.2 $2.14 8/15/20222,900 shares $6,583.00 No ChangeN/A4.8 $2.27 7/31/20222,900 shares $6,757.00 No ChangeN/A9.7 $2.33 7/15/20222,900 shares $6,003.00 No ChangeN/A2.6 $2.07 6/30/20222,900 shares $7,250.00 No ChangeN/A0.9 $2.50 6/15/20222,900 shares $6,438.00 -3.3%N/A1.9 $2.22 5/31/20223,000 shares $7,500.00 +3.5%N/A0.9 $2.50M.A.G.A. is Finished – This Could be even Better (Ad)You’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big change. Make America Wealthy Again (M.A.W.A).When you see what could happen – I think you’ll be excited. 5/15/20222,900 shares $8,555.00 No ChangeN/A1.4 $2.95 4/30/20222,900 shares $8,990.00 No ChangeN/A2.2 $3.10 4/15/20222,900 shares $9,947.00 No ChangeN/A0.5 $3.43 3/31/20222,900 shares $10,208.00 -14.7%N/A0.9 $3.52 3/15/20223,400 shares $12,274.00 +9.7%N/A1.7 $3.61 2/28/20223,100 shares $12,400.00 -3.1%N/A0.7 $4.00 2/15/20223,200 shares $13,408.00 +10.3%N/A0.6 $4.19 1/31/20222,900 shares $11,890.00 No ChangeN/A0.9 $4.10 1/15/20222,900 shares $12,325.00 -14.7%N/A0.6 $4.25 12/31/20213,400 shares $14,722.00 +17.2%N/A0.6 $4.33 12/15/20212,900 shares $13,485.00 No ChangeN/A1.3 $4.65 11/30/20212,900 shares $13,485.00 No ChangeN/A0.9 $4.65 11/15/20212,900 shares $13,775.00 -3.3%N/A0.6 $4.75 10/29/20213,000 shares $15,000.00 +3.5%N/A0.3 $5.00 10/15/20212,900 shares $11,600.00 No ChangeN/A1.5 $4.00 9/30/20212,900 shares $11,049.00 -9.4%N/A0.9 $3.81 9/15/20213,200 shares $12,032.00 +6.7%N/A0.5 $3.76 8/31/20213,000 shares $10,800.00 -25.0%N/A2.3 $3.60 8/13/20214,000 shares $15,120.00 +8.1%N/A3.1 $3.78 7/30/20213,700 shares $15,077.50 +27.6%N/A1.3 $4.08 7/15/20212,900 shares $12,064.00 -3.3%N/A1.2 $4.16 6/30/20213,000 shares $12,540.00 -25.0%N/A1.9 $4.18 6/15/20214,000 shares $17,800.00 -2.4%N/A0.9 $4.45 5/28/20214,100 shares $20,090.00 -4.7%N/A0.9 $4.90 5/14/20214,300 shares $25,800.00 +22.9%N/A0.7 $6.00 4/30/20213,500 shares $10,325.00 No ChangeN/A1.7 $2.95 4/15/20213,500 shares $9,782.50 +2.9%N/A1.1 $2.80 3/31/20213,400 shares $7,208.00 No ChangeN/A0.4 $2.12 3/15/20213,400 shares $8,500.00 No ChangeN/A0.5 $2.50 2/26/20213,400 shares $6,460.00 -2.9%N/A0.8 $1.90 2/12/20213,500 shares $8,400.00 +2.9%N/A0.4 $2.40 1/29/20213,400 shares $5,270.00 No ChangeN/A0.7 $1.55 1/15/20213,400 shares $4,352.00 No ChangeN/A3.1 $1.28 12/31/20203,400 shares $3,366.00 No ChangeN/A0.7 $0.99 12/15/20203,400 shares $4,318.00 No ChangeN/A3.1 $1.27 11/30/20203,400 shares $5,440.00 No ChangeN/A8.5 $1.60 11/15/20203,400 shares $5,950.00 No ChangeN/A1.7 $1.75 10/30/20203,400 shares $5,406.00 -22.7%N/A0.9 $1.59 10/15/20204,400 shares $7,612.00 No ChangeN/A2 $1.73 9/30/20204,400 shares $8,360.00 +10.0%N/A2.3 $1.90 9/15/20204,000 shares $7,400.00 +17.7%N/A0.4 $1.85 8/31/20203,400 shares $7,548.00 No ChangeN/A2.3 $2.22 8/14/20203,400 shares $8,500.00 -5.6%N/A1.4 $2.50 7/31/20203,600 shares $9,072.00 +5.9%N/A2.6 $2.52 7/15/20203,400 shares $9,129.00 -15.0%N/A1.6 $2.69 6/30/20204,000 shares $11,360.00 +2.6%N/A5.7 $2.84 6/15/20203,900 shares $12,168.00 No ChangeN/A0.6 $3.12 5/29/20203,900 shares $11,700.00 +2.6%N/A1.4 $3.00 5/15/20203,800 shares $7,562.00 -44.9%N/A2.9 $1.99 4/30/20206,900 shares $13,455.00 +32.7%N/A1.3 $1.95M.A.G.A. is Finished – This Could be even Better (Ad)You’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big change. Make America Wealthy Again (M.A.W.A).When you see what could happen – I think you’ll be excited. BICX Short Interest - Frequently Asked Questions What is BioCorRx's current short interest? Short interest is the volume of BioCorRx shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 8,800 shares of BICX short. 0.07% of BioCorRx's shares are currently sold short. Learn More on BioCorRx's current short interest. What is a good short interest ratio for BioCorRx? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BICX shares currently have a short interest ratio of 1.0. Learn More on BioCorRx's short interest ratio. What is a good short interest percentage for BioCorRx? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.07% of BioCorRx's floating shares are currently sold short. Is BioCorRx's short interest increasing or decreasing? BioCorRx saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 8,800 shares, an increase of 23.9% from the previous total of 7,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioCorRx's short interest compare to its competitors? 0.07% of BioCorRx's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to BioCorRx: Burning Rock Biotech Limited (0.56%), Concord Medical Services Holdings Limited (0.61%), American Shared Hospital Services (1.29%), Enzo Biochem, Inc. (0.97%), PharmChem, Inc. (0.01%), Mangoceuticals, Inc. (7.08%), BioRestorative Therapies, Inc. (6.07%), Kindly MD, Inc. (7.27%), Pacific Health Care Organization, Inc. (0.01%), Xcelerate Inc. (0.01%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short BioCorRx stock? Short selling BICX is an investing strategy that aims to generate trading profit from BioCorRx as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioCorRx? A short squeeze for BioCorRx occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BICX, which in turn drives the price of the stock up even further. How often is BioCorRx's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BICX, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Burning Rock Biotech Short Interest Data Concord Medical Services Short Interest Data American Shared Hospital Services Short Interest Data Enzo Biochem Short Interest Data PharmChem Short Interest Data Mangoceuticals Short Interest Data BioRestorative Therapies Short Interest Data Kindly MD Short Interest Data Pacific Health Care Organization Short Interest Data Xcelerate Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:BICX) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioCorRx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioCorRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.